ABT-288 is under investigation in clinical trial NCT01018875 (Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.